SGD Pharma, announces the opening of a new siliconization operation at its state-of-the-art Saint-Quentin Lamotte (SQLM) plant. The company enhances its already extensive range of in-house services by ...
As part of a range of sustainable products and services that SGD Pharma plans to showcase at CPHI Milan, the company will introduce its siliconized molded glass vials. On Oct. 1, 2024, SGD Pharma, a ...